IBDEI08H ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11136,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,11136,2)
 ;;=DM Type II, No Retinopathy^33605
 ;;^UTILITY(U,$J,358.3,11137,0)
 ;;=250.01^^73^701^33
 ;;^UTILITY(U,$J,358.3,11137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11137,1,3,0)
 ;;=3^Dm Type I, No Retinopathy
 ;;^UTILITY(U,$J,358.3,11137,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,11137,2)
 ;;=DM Type I, No Retinopathy^33586
 ;;^UTILITY(U,$J,358.3,11138,0)
 ;;=250.50^^73^701^25
 ;;^UTILITY(U,$J,358.3,11138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11138,1,3,0)
 ;;=3^Csme In DM Type II
 ;;^UTILITY(U,$J,358.3,11138,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,11138,2)
 ;;=CSME in DM type II^267839^362.83
 ;;^UTILITY(U,$J,358.3,11139,0)
 ;;=250.51^^73^701^27
 ;;^UTILITY(U,$J,358.3,11139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11139,1,3,0)
 ;;=3^DM Type I w/ Ophtharlmic Manifestation
 ;;^UTILITY(U,$J,358.3,11139,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,11139,2)
 ;;=CSME in DM Type I^267840^362.83
 ;;^UTILITY(U,$J,358.3,11140,0)
 ;;=362.01^^73^701^32
 ;;^UTILITY(U,$J,358.3,11140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11140,1,3,0)
 ;;=3^Diabetic Retinopathy Nos
 ;;^UTILITY(U,$J,358.3,11140,1,4,0)
 ;;=4^362.01
 ;;^UTILITY(U,$J,358.3,11140,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,11141,0)
 ;;=362.02^^73^701^72
 ;;^UTILITY(U,$J,358.3,11141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11141,1,3,0)
 ;;=3^Prolif Diab Retinopathy
 ;;^UTILITY(U,$J,358.3,11141,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,11141,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,11142,0)
 ;;=362.03^^73^701^64
 ;;^UTILITY(U,$J,358.3,11142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11142,1,3,0)
 ;;=3^Nonprolf Db Retnoph Nos
 ;;^UTILITY(U,$J,358.3,11142,1,4,0)
 ;;=4^362.03
 ;;^UTILITY(U,$J,358.3,11142,2)
 ;;=^332786
 ;;^UTILITY(U,$J,358.3,11143,0)
 ;;=362.04^^73^701^61
 ;;^UTILITY(U,$J,358.3,11143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11143,1,3,0)
 ;;=3^Mild Nonprolf Db Retnoph
 ;;^UTILITY(U,$J,358.3,11143,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,11143,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,11144,0)
 ;;=362.05^^73^701^62
 ;;^UTILITY(U,$J,358.3,11144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11144,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,11144,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,11144,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,11145,0)
 ;;=362.06^^73^701^98
 ;;^UTILITY(U,$J,358.3,11145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11145,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,11145,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,11145,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,11146,0)
 ;;=379.27^^73^701^103
 ;;^UTILITY(U,$J,358.3,11146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11146,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,11146,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,11146,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,11147,0)
 ;;=115.02^^73^701^44
 ;;^UTILITY(U,$J,358.3,11147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11147,1,3,0)
 ;;=3^Histoplasma Capsulatum Retinitis
 ;;^UTILITY(U,$J,358.3,11147,1,4,0)
 ;;=4^115.02
 ;;^UTILITY(U,$J,358.3,11147,2)
 ;;=^266890
 ;;^UTILITY(U,$J,358.3,11148,0)
 ;;=190.5^^73^701^58
 ;;^UTILITY(U,$J,358.3,11148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11148,1,3,0)
 ;;=3^Malig Retina
 ;;^UTILITY(U,$J,358.3,11148,1,4,0)
 ;;=4^190.5
 ;;^UTILITY(U,$J,358.3,11148,2)
 ;;=^73530
 ;;^UTILITY(U,$J,358.3,11149,0)
 ;;=198.4^^73^701^59
 ;;^UTILITY(U,$J,358.3,11149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11149,1,3,0)
 ;;=3^Malig Secondary Choroid
 ;;^UTILITY(U,$J,358.3,11149,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,11149,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,11150,0)
 ;;=200.00^^73^701^81
 ;;^UTILITY(U,$J,358.3,11150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11150,1,3,0)
 ;;=3^Reticulosarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,11150,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,11150,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,11151,0)
 ;;=228.03^^73^701^38
 ;;^UTILITY(U,$J,358.3,11151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11151,1,3,0)
 ;;=3^Hemangioma Retina
 ;;^UTILITY(U,$J,358.3,11151,1,4,0)
 ;;=4^228.03
 ;;^UTILITY(U,$J,358.3,11151,2)
 ;;=^267700
 ;;^UTILITY(U,$J,358.3,11152,0)
 ;;=228.09^^73^701^39
 ;;^UTILITY(U,$J,358.3,11152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11152,1,3,0)
 ;;=3^Hemangioma,Oth Sites
 ;;^UTILITY(U,$J,358.3,11152,1,4,0)
 ;;=4^228.09
 ;;^UTILITY(U,$J,358.3,11152,2)
 ;;=^55270
 ;;^UTILITY(U,$J,358.3,11153,0)
 ;;=360.00^^73^701^73
 ;;^UTILITY(U,$J,358.3,11153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11153,1,3,0)
 ;;=3^Purulent Endophthalmitis,Unspec
 ;;^UTILITY(U,$J,358.3,11153,1,4,0)
 ;;=4^360.00
 ;;^UTILITY(U,$J,358.3,11153,2)
 ;;=^40605
 ;;^UTILITY(U,$J,358.3,11154,0)
 ;;=360.03^^73^701^21
 ;;^UTILITY(U,$J,358.3,11154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11154,1,3,0)
 ;;=3^Chronic Endophthalmitis
 ;;^UTILITY(U,$J,358.3,11154,1,4,0)
 ;;=4^360.03
 ;;^UTILITY(U,$J,358.3,11154,2)
 ;;=^268547
 ;;^UTILITY(U,$J,358.3,11155,0)
 ;;=361.02^^73^701^76
 ;;^UTILITY(U,$J,358.3,11155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11155,1,3,0)
 ;;=3^Recent RD w/ Multiple Defects
 ;;^UTILITY(U,$J,358.3,11155,1,4,0)
 ;;=4^361.02
 ;;^UTILITY(U,$J,358.3,11155,2)
 ;;=^268587
 ;;^UTILITY(U,$J,358.3,11156,0)
 ;;=361.03^^73^701^75
 ;;^UTILITY(U,$J,358.3,11156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11156,1,3,0)
 ;;=3^Recent RD w/ Giant Tear
 ;;^UTILITY(U,$J,358.3,11156,1,4,0)
 ;;=4^361.03
 ;;^UTILITY(U,$J,358.3,11156,2)
 ;;=^268588
 ;;^UTILITY(U,$J,358.3,11157,0)
 ;;=361.04^^73^701^79
 ;;^UTILITY(U,$J,358.3,11157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11157,1,3,0)
 ;;=3^Ret Det,Partial w/ Dialysis
 ;;^UTILITY(U,$J,358.3,11157,1,4,0)
 ;;=4^361.04
 ;;^UTILITY(U,$J,358.3,11157,2)
 ;;=^268589
 ;;^UTILITY(U,$J,358.3,11158,0)
 ;;=361.12^^73^701^8
 ;;^UTILITY(U,$J,358.3,11158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11158,1,3,0)
 ;;=3^Bullous Retinoschisis
 ;;^UTILITY(U,$J,358.3,11158,1,4,0)
 ;;=4^361.12
 ;;^UTILITY(U,$J,358.3,11158,2)
 ;;=^268596
 ;;^UTILITY(U,$J,358.3,11159,0)
 ;;=361.2^^73^701^102
 ;;^UTILITY(U,$J,358.3,11159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11159,1,3,0)
 ;;=3^Uveal Effusion/SRD
 ;;^UTILITY(U,$J,358.3,11159,1,4,0)
 ;;=4^361.2
 ;;^UTILITY(U,$J,358.3,11159,2)
 ;;=^268601
 ;;^UTILITY(U,$J,358.3,11160,0)
 ;;=361.9^^73^701^83
 ;;^UTILITY(U,$J,358.3,11160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11160,1,3,0)
 ;;=3^Retinal Detachment NOS
 ;;^UTILITY(U,$J,358.3,11160,1,4,0)
 ;;=4^361.9
 ;;^UTILITY(U,$J,358.3,11160,2)
 ;;=^105529
 ;;^UTILITY(U,$J,358.3,11161,0)
 ;;=362.10^^73^701^95
 ;;^UTILITY(U,$J,358.3,11161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11161,1,3,0)
 ;;=3^Rubella Retinopathy
 ;;^UTILITY(U,$J,358.3,11161,1,4,0)
 ;;=4^362.10
 ;;^UTILITY(U,$J,358.3,11161,2)
 ;;=^12267
 ;;^UTILITY(U,$J,358.3,11162,0)
 ;;=362.12^^73^701^22
 ;;^UTILITY(U,$J,358.3,11162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11162,1,3,0)
 ;;=3^Coats' Disease
 ;;^UTILITY(U,$J,358.3,11162,1,4,0)
 ;;=4^362.12
 ;;^UTILITY(U,$J,358.3,11162,2)
 ;;=^268612
 ;;^UTILITY(U,$J,358.3,11163,0)
 ;;=362.13^^73^701^88
 ;;^UTILITY(U,$J,358.3,11163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11163,1,3,0)
 ;;=3^Retinal Vascular Changes
 ;;^UTILITY(U,$J,358.3,11163,1,4,0)
 ;;=4^362.13
 ;;^UTILITY(U,$J,358.3,11163,2)
 ;;=^268614
 ;;^UTILITY(U,$J,358.3,11164,0)
 ;;=362.14^^73^701^82
 ;;^UTILITY(U,$J,358.3,11164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11164,1,3,0)
 ;;=3^Retina Microaneurysm NOS
 ;;^UTILITY(U,$J,358.3,11164,1,4,0)
 ;;=4^362.14
 ;;^UTILITY(U,$J,358.3,11164,2)
 ;;=^268615
 ;;^UTILITY(U,$J,358.3,11165,0)
 ;;=362.17^^73^701^52
 ;;^UTILITY(U,$J,358.3,11165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11165,1,3,0)
 ;;=3^Macroaneurysm
 ;;^UTILITY(U,$J,358.3,11165,1,4,0)
 ;;=4^362.17
 ;;^UTILITY(U,$J,358.3,11165,2)
 ;;=^268617
 ;;^UTILITY(U,$J,358.3,11166,0)
 ;;=362.21^^73^701^71
 ;;^UTILITY(U,$J,358.3,11166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11166,1,3,0)
 ;;=3^Prematurity-ROP
 ;;^UTILITY(U,$J,358.3,11166,1,4,0)
 ;;=4^362.21
 ;;^UTILITY(U,$J,358.3,11166,2)
 ;;=^105733
 ;;^UTILITY(U,$J,358.3,11167,0)
 ;;=362.29^^73^701^63
 ;;^UTILITY(U,$J,358.3,11167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11167,1,3,0)
 ;;=3^Nondiabetic PR
 ;;^UTILITY(U,$J,358.3,11167,1,4,0)
 ;;=4^362.29
 ;;^UTILITY(U,$J,358.3,11167,2)
 ;;=^268619
 ;;^UTILITY(U,$J,358.3,11168,0)
 ;;=362.30^^73^701^40
 ;;^UTILITY(U,$J,358.3,11168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11168,1,3,0)
 ;;=3^Hemiretinal Vein Occlusion
 ;;^UTILITY(U,$J,358.3,11168,1,4,0)
 ;;=4^362.30
 ;;^UTILITY(U,$J,358.3,11168,2)
 ;;=^105640
 ;;^UTILITY(U,$J,358.3,11169,0)
 ;;=362.37^^73^701^9
 ;;^UTILITY(U,$J,358.3,11169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11169,1,3,0)
 ;;=3^CRVO-Partial
 ;;^UTILITY(U,$J,358.3,11169,1,4,0)
 ;;=4^362.37
 ;;^UTILITY(U,$J,358.3,11169,2)
 ;;=^268627
 ;;^UTILITY(U,$J,358.3,11170,0)
 ;;=362.50^^73^701^51
 ;;^UTILITY(U,$J,358.3,11170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11170,1,3,0)
 ;;=3^Mac Degen,Senile/Atrophy
 ;;^UTILITY(U,$J,358.3,11170,1,4,0)
 ;;=4^362.50
 ;;^UTILITY(U,$J,358.3,11170,2)
 ;;=^73072
 ;;^UTILITY(U,$J,358.3,11171,0)
 ;;=362.70^^73^701^28
 ;;^UTILITY(U,$J,358.3,11171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11171,1,3,0)
 ;;=3^Degen/Hered Disorder
 ;;^UTILITY(U,$J,358.3,11171,1,4,0)
 ;;=4^362.70
 ;;^UTILITY(U,$J,358.3,11171,2)
 ;;=^268650
 ;;^UTILITY(U,$J,358.3,11172,0)
 ;;=362.74^^73^701^91
 ;;^UTILITY(U,$J,358.3,11172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11172,1,3,0)
 ;;=3^Retinitis Pigmentosa
 ;;^UTILITY(U,$J,358.3,11172,1,4,0)
 ;;=4^362.74
 ;;^UTILITY(U,$J,358.3,11172,2)
 ;;=^105693
 ;;^UTILITY(U,$J,358.3,11173,0)
 ;;=362.75^^73^701^50
 ;;^UTILITY(U,$J,358.3,11173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11173,1,3,0)
 ;;=3^Mac Degen,Juvenile
